• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
XVIVO
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
    • Info
    • Ownership structure
    • Insiders (PDMRs)
  • Press releases
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Financial reports – ESEF
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
    • Capital Markets Day
    • Earnings calls
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • Code of Conduct
  • Environmental Policy
  • Code of Conduct for Suppliers
  • Privacy policy
  • Contact us
  • Subscribe
  • Thank you
  • Error

Press releases 2021

  • All press releases
  • Regulatory Press Releases
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2021-12-21 13:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO accelerates their business in Brazil by signing a partnership contract with Contatti Medical
2021-12-21 13:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO accelererar sin verksamhet i Brasilien genom att teckna ett partnerskapsavtal med Contatti Medical
2021-12-08 10:00
News
IR
English
Corporate Information
Staff change
In-line with XVIVO’s dedication to the US market, Fredrik Dalborg is appointed Managing Director North America
2021-12-08 10:00
News
IR
Swedish
Corporate Information
Staff change
I linje med XVIVOs fokus på den amerikanska marknaden har Fredrik Dalborg utsetts till Managing Director för Nordamerika
2021-11-30 08:00
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2021-11-30 08:00
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2021-11-22 15:00
News
IR
English
Corporate Information
Staff change
XVIVO expands its management team by appointing Jaya Tiwari to Vice President Clinical and Regulatory Affairs for the US
2021-11-22 15:00
News
IR
Swedish
Corporate Information
Staff change
XVIVO utökar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs för USA
2021-11-09 19:45
News
IR
Swedish
Corporate Action
M&A
XVIVO slutför förvärvet av Star Teams Inc.
2021-11-09 19:45
News
IR
English
Corporate Action
M&A
XVIVO completes the acquisition of Star Teams Inc.
2021-10-28 21:58
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 746,269 shares at a subscription price of SEK 335 per share
2021-10-28 21:58
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 746 269 aktier till en teckningskurs om 335 kronor per aktie
2021-10-28 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2021-10-28 17:31
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2021-10-28 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO has entered into an agreement to acquire the US organ recovery company Star Teams and finances the acquisition through a private placement of new shares
2021-10-28 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO har ingått avtal om att förvärva det amerikanska företaget för organhämtning, Star Teams, och finansierar förvärvet genom en nyemission av aktier
2021-10-21 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO offentliggör delårsrapport januari-september 2021
2021-10-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO presents interim report Januari-September 2021
2021-10-18 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Rekord för ett donatorhjärta utanför kroppen med banbrytande teknologi från XVIVO
2021-10-18 15:00
News
IR
English
Corporate Information
Other Corporate Information
Record for a donor heart outside the body using ground-breaking XVIVO technology
2021-10-07 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2021-10-07 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2021-10-05 11:30
News
IR
English
Corporate Information
Financial calendar
Advance publication of interim report January-September 2021
2021-10-05 11:30
News
IR
Swedish
Corporate Information
Financial calendar
Tidigareläggning av delårsrapport januari-september 2021
2021-09-30 08:30
News
IR
English
Corporate Information
Nomination Committee
Nomination committee of XVIVO Perfusion AB (publ)
2021-09-30 08:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2021-09-23 09:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-09-23 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO presenterar strategiska fokusområden för 2022-2026 på kapitalmarknadsdagen
2021-09-23 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-08-23 17:00
News
IR
English
Corporate Information
Presentation
XVIVO Capital Markets Day 2021
2021-08-23 17:00
News
IR
Swedish
Corporate Information
Presentation
XVIVO’s kapitalmarknadsdag 2021
2021-07-13 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO offentliggör delårsrapport Januari-Juni 2021
2021-07-13 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO presents interim report January-June 2021
2021-07-08 15:45
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO startar sin digitala transformationsresa tillsammans med UMC Groningen för att möjliggöra en ökning av framgångsrika transplantationer
2021-07-08 15:45
News
IR
English
Corporate Information
Other Corporate Information
XVIVO to start their digital transformation journey together with UMC Groningen to enable an increase in successful transplants
2021-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2021-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2021-06-28 08:30
News
IR
English
Corporate Information
Financial calendar
Conference call on Interim Report
2021-06-28 08:30
News
IR
Swedish
Corporate Information
Financial calendar
Telefonkonferens avseende delårsrapport
2021-05-28 14:08
News
IR
Swedish
Corporate Information
Other Corporate Information
National Institute for Health and Care Excellence (NICE) i Storbritannien ger stöd för EVLP
2021-05-28 14:08
News
IR
English
Corporate Information
Other Corporate Information
The National Institute for Health and Care Excellence (NICE) Gives Support for EVLP
2021-05-25 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Stort intresse för XVIVO:s europeiska hjärtstudie
2021-05-25 10:30
News
IR
English
Corporate Information
Other Corporate Information
Great interest for XVIVO's European heart study
2021-05-04 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
510(k)-ansökan för Kidney Assist Transport inlämnad till amerikanska FDA
2021-05-04 07:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO submits 510(k) file with US FDA for Kidney Assist Transport
2021-04-22 16:12
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2021-04-22 16:12
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
2021-04-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim report January-March 2021
2021-04-21 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Delårsrapport januari-mars 2021
2021-04-19 08:30
News
IR
English
Corporate Information
Other Corporate Information
Australian heart preservation study underway
2021-04-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten transplanterad i australiensisk hjärtstudie.
2021-04-08 08:22
News
IR
Swedish
Correction
Corporate Information
Other Corporate Information
Rättelse: Telefonkonferens avseende delårsrapport
2021-04-08 07:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2021-04-08 07:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2021-03-29 12:35
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2020
2021-03-29 12:35
News
IR
English
Regulatory
VPML
Report
Annual
Annual report 2020
2021-03-15 08:50
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)
2021-03-15 08:50
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2021-02-26 16:30
News
IR
English
Corporate Information
Other Corporate Information
Publication in The New England Journal of Medicine shows complications after liver transplantation significantly reduced with cold, oxygenated machine perfusion.
2021-02-26 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Publikation i The New England Journal of Medicine visar på signifikant minskning av komplikationer efter levertransplantation med syresatt, kall maskinperfusion
2021-01-28 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
XVIVO offentliggör bokslutskommuniké 2020
2021-01-28 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
XVIVO presents Report on operations 2020
2021-01-08 16:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2021-01-08 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2021-11-30 08:00
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2021-11-30 08:00
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2021-10-28 21:58
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 746,269 shares at a subscription price of SEK 335 per share
2021-10-28 21:58
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 746 269 aktier till en teckningskurs om 335 kronor per aktie
2021-10-28 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2021-10-28 17:31
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2021-10-28 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO has entered into an agreement to acquire the US organ recovery company Star Teams and finances the acquisition through a private placement of new shares
2021-10-28 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO har ingått avtal om att förvärva det amerikanska företaget för organhämtning, Star Teams, och finansierar förvärvet genom en nyemission av aktier
2021-10-21 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO offentliggör delårsrapport januari-september 2021
2021-10-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO presents interim report Januari-September 2021
2021-09-23 09:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-09-23 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO presenterar strategiska fokusområden för 2022-2026 på kapitalmarknadsdagen
2021-09-23 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-07-13 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO offentliggör delårsrapport Januari-Juni 2021
2021-07-13 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO presents interim report January-June 2021
2021-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2021-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2021-04-22 16:12
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2021-04-22 16:12
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
2021-04-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim report January-March 2021
Next
About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

 

Report a violations or breach here: Whistleblower

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve